Skip to content

Clinical trials

Phase 2 Pulmonary Fibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20181
20201
20221
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Amgen1
Assistance Publique - Hôpitaux de Paris1
Avalyn Pharma Inc.1
Bristol-Myers Squibb1
Contineum Therapeutics1
Debiopharm International SA1
Endeavor Biomedicines, Inc.1
Pliant Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis10
Idiopathic Pulmonary Fibrosis5
Lung Diseases, Interstitial4
Alveolitis, Extrinsic Allergic1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Fibrosis1
Idiopathic Interstitial Pneumonias1
Inflammation1
Lung Diseases1
Microscopic Polyangiitis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.